The Current Ratio as of December 2024 (TTM) for Manhattan Scientifics, Inc. (MHTX) is 0.02

According to Manhattan Scientifics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.02. This represents a change of -39.44% compared to the average of 0.03 of the last 4 quarters.

Manhattan Scientifics, Inc. (MHTX) Historical Current Ratio (quarterly & annually)

How has MHTX Current Ratio performed in the past?

The mean historical Current Ratio of Manhattan Scientifics, Inc. over the last ten years is 0.79. The current 0.02 Current Ratio has changed 134.95% with respect to the historical average. Over the past ten years (40 quarters), MHTX's Current Ratio was at its highest in in the September 2015 quarter at 5.86. The Current Ratio was at its lowest in in the June 2024 quarter at 0.02.

Manhattan Scientifics, Inc. (MHTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Manhattan Scientifics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Manhattan Scientifics, Inc. (MHTX) Average Current Ratio

How has MHTX Current Ratio performed in the past?

The current Current Ratio of Manhattan Scientifics, Inc. (MHTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Manhattan Scientifics, Inc. (MHTX) Current Ratio vs. Peers

How is MHTX’s Current Ratio compared to its peers?

Manhattan Scientifics, Inc.’s Current Ratio is less than VentriPoint Diagnostics Ltd. (0.28), less than Cannabix Technologies Inc. (17.87), less than Accelerate Diagnostics, Inc. (1.50), less than Venus Concept Inc. (1.86), less than Nemaura Medical Inc. (0.19), less than Bluejay Diagnostics, Inc. (6.26), less than Movano Inc. (3.31), less than INVO Bioscience, Inc. (0), less than enVVeno Medical Corporation (22.01), less than OpGen, Inc. (5.46), less than Biomerica, Inc. (3.00), less than BIOLASE, Inc. (0.71), less than Semler Scientific, Inc. (3.14), less than NanoVibronix, Inc. (1.74), less than Asensus Surgical, Inc. (0.49), less than DexCom, Inc. (2.46), less than Tandem Diabetes Care, Inc. (2.90), less than Pacific Biosciences of California, Inc. (9.74), less than Nano-X Imaging Ltd. (4.64),

Build a custom stock screener for Manhattan Scientifics, Inc. (MHTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Manhattan Scientifics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Manhattan Scientifics, Inc. (MHTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Manhattan Scientifics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.